Most start-ups wouldn’t employ the strategy that PostEra has. In fact, many of its business decisions seem counterintuitive. PostEra owns little to no intellectual property (IP) on its early work, ...
CMS has clarified the situations in which a pharmacy can bill for dispensing certain drugs, according to an AAPC release. The situation has been clarified in Transmittal 2312, posted by CMS. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback